CS Medica Cash Flow Statement

Financials in millions DKK. Fiscal year is October - September.

Millions DKK. Fiscal year is Oct - Sep.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
Net Income	-9.65	-14.51	-10.8	0.65	-0.05
Depreciation & Amortization	2.12	0.48	0.48	0.36	0.38
Other Amortization	-	1.6	1.6	1.01	-
Other Operating Activities	1.53	0.57	0.83	0.23	0.12
Change in Accounts Receivable	-1.72	4.13	-3.45	-3.1	0.04
Change in Inventory	1.75	-1.36	-0.18	-0.04	-0.66
Change in Accounts Payable	5.71	4.89	0.71	0.03	0.7
Change in Other Net Operating Assets	0.74	-0.16	0.09	-5.39	0.13
Operating Cash Flow	-4.35	-8.33	-14.04	-6.02	0.67
Operating Cash Flow Growth	-	-	-	-	-41.00%
Sale (Purchase) of Intangibles	-3.35	-2.19	-2.81	-4.16	-1.73
Investing Cash Flow	-3.35	-2.19	-2.81	-4.16	-1.73
Short-Term Debt Issued	3.55	-	0.04	0.26	-
Long-Term Debt Issued	0.05	8.1	-	1.43	-
Total Debt Issued	3.6	8.1	0.04	1.69	-
Short-Term Debt Repaid	-	-0.26	-	-	-
Long-Term Debt Repaid	-0.01	-0.11	-0.72	-5.43	-0.29
Total Debt Repaid	-0.01	-0.36	-0.72	-5.43	-0.29
Net Debt Issued (Repaid)	3.6	7.74	-0.68	-3.74	-0.29
Issuance of Common Stock	11.56	-	13.39	27.57	2.19
Other Financing Activities	-7.84	-0.57	-2.92	-3.95	-0.14
Financing Cash Flow	7.33	7.17	9.79	19.88	1.76
Miscellaneous Cash Flow Adjustments	-	0	-	-	-
Net Cash Flow	-0.38	-3.35	-7.06	9.7	0.69
Free Cash Flow	-4.35	-8.33	-14.04	-6.02	0.67
Free Cash Flow Growth	-	-	-	-	-41.00%
Free Cash Flow Margin	-51.43%	-780.39%	-132.68%	-189.30%	31.58%
Free Cash Flow Per Share	-0.25	-0.68	-1.21	-1.10	-
Cash Interest Paid	1.53	0.57	0.83	0.23	0.14
Levered Free Cash Flow	-4.26	-4	-12.55	-5.34	-1.21
Unlevered Free Cash Flow	-3.3	-3.64	-12.03	-5.2	-1.12

Source: S&P Global Market Intelligence. Standard template. Financial Sources.